Is ALNY or IQV cheaper?

On trailing earnings, IQV is cheaper: ALNY trades at a 66.81 P/E and IQV at 25.75.

Which has grown faster, ALNY or IQV?

Over the past five years, ALNY grew revenue faster — ALNY at a 49.67% CAGR versus IQV at 6.72%.

Is ALNY or IQV more profitable?

ALNY runs the higher net margin — ALNY at 13.46% versus IQV at 8.33%.

Which has been the better investment, ALNY or IQV?

Over the past 10-year, ALNY delivered the higher annualized total return — ALNY at 16.14% versus IQV at 11.06%. Past performance doesn't predict future results.

Alnylam Pharmaceuticals, Inc. (ALNY) vs IQVIA Holdings Inc. (IQV)

ALNY leads on 8 of 14 compared metrics, though IQV is the cheaper stock.

A side-by-side comparison of Alnylam Pharmaceuticals, Inc. and IQVIA Holdings Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 15, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

ALNY

Alnylam Pharmaceuticals, Inc.

$37.54B

$281.19HealthcareDelayed quote: Jul 15, 2026, 10:50 AM EDT

IQV

IQVIA Holdings Inc.

$34.93B

$209.28HealthcareDelayed quote: Jul 15, 2026, 10:50 AM EDT

Total return — ALNY vs IQV

growth of $100 · dividends reinvested · last 13y

ALNY +1044.3%IQV +393.5%ALNY compounded faster

ALNY IQV

ALNY vs IQV: by the numbers

•ALNY is the larger company ($37.54B vs $34.93B market cap).
•IQV trades at the lower earnings multiple (25.75 vs 66.81 P/E).
•ALNY converts more revenue to profit (13.46% vs 8.33% net margin).
•ALNY grew revenue faster over the past five years (49.67% vs 6.72% CAGR).

Which is better, ALNY or IQV?

Metric tally: ALNY 8 · IQV 6

It depends on what you're optimizing for:

ValueIQV(lower P/E)

GrowthALNY(faster 5Y revenue CAGR)

QualityALNY(higher ROIC)

Metrics side by side

Valuation

Metric	ALNY	IQV
P/E ratio	66.81	25.75●
Forward P/E	37.91	16.23●
P/S ratio	9.07	2.12●
P/B ratio	36.15	5.67●
PEG ratio	—	6.34
EV / EBITDA	47.64	14.23●
FCF yield	1.65%	7.21%●

Profitability

Metric	ALNY	IQV
Gross margin	80.89%●	26.11%
Operating margin	17.54%●	13.86%
Net margin	13.46%●	8.33%
ROE	53.68%●	22.26%
ROIC	13.74%●	8.23%

Growth (annualized)

Metric	ALNY	IQV
Revenue CAGR (5Y)	49.67%●	6.72%
EPS CAGR (5Y)	—	40.21%
FCF CAGR (5Y)	14.35%●	4.53%
Total return CAGR (5Y)	10.55%●	-3.32%

Frequently asked

Which is better, ALNY or IQV?: It depends on your goal. value: IQV (lower P/E); growth: ALNY (faster 5Y revenue CAGR); quality: ALNY (higher ROIC). Across all compared metrics, ALNY leads 8 to 6.
Is ALNY or IQV cheaper?: On trailing earnings, IQV is cheaper: ALNY trades at a 66.81 P/E and IQV at 25.75.
Which has grown faster, ALNY or IQV?: Over the past five years, ALNY grew revenue faster — ALNY at a 49.67% CAGR versus IQV at 6.72%.
Is ALNY or IQV more profitable?: ALNY runs the higher net margin — ALNY at 13.46% versus IQV at 8.33%.
Which has been the better investment, ALNY or IQV?: Over the past 10-year, ALNY delivered the higher annualized total return — ALNY at 16.14% versus IQV at 11.06%. Past performance doesn't predict future results.

Go deeper

Full ALNY analysis Full IQV analysis Interactive comparison tool

Dig into the metrics

Alnylam Pharmaceuticals P/E ratio IQVIA P/E ratio Alnylam Pharmaceuticals dividend yield IQVIA dividend yield Alnylam Pharmaceuticals ROE IQVIA ROE Alnylam Pharmaceuticals operating margin IQVIA operating margin Alnylam Pharmaceuticals revenue growth IQVIA revenue growth Alnylam Pharmaceuticals free cash flow IQVIA free cash flow

Alnylam Pharmaceuticals & IQVIA appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest FCF Yield Stocks Best 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 15, 2026.